Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
10058-F4
i
Other names:
10058-F4
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Children's Hospital of Pittsburgh of UPMC, UPMC Hillman Cancer Center
Drug class:
MYC inhibitor
Related drugs:
‹
GT19077 (14)
omacetaxine mepesuccinate (4)
WB100 (3)
PLX51107 (2)
RRx-001 (2)
ICX-101 (1)
MYCi975 (1)
OMO-103 (1)
APTO-253 (0)
IDP-121 (0)
LMP744 (0)
MRX34 (0)
OTX-2002 (0)
GT19077 (14)
omacetaxine mepesuccinate (4)
WB100 (3)
PLX51107 (2)
RRx-001 (2)
ICX-101 (1)
MYCi975 (1)
OMO-103 (1)
APTO-253 (0)
IDP-121 (0)
LMP744 (0)
MRX34 (0)
OTX-2002 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
MAF overexpression
Multiple Myeloma
MAF overexpression
Multiple Myeloma
JQ-1 + 10058-F4
Resistant: C3 – Early Trials
JQ-1 + 10058-F4
Resistant
:
C3
JQ-1 + 10058-F4
Resistant: C3 – Early Trials
JQ-1 + 10058-F4
Resistant
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login